Abstract
We investigated the effect of the menopause and postmenopausal hormone replacement therapy (HRT) on the serum concentration of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen (ICTP), a potential new biochemical marker of bone resorption. A group of 44 healthy postmenopausal women, aged 45–54 years, had about 19% higher serum ICTP than did a group of 42 healthy premenopausal women aged 35–50 years (3.6±0.8 µg/l v 3.0±0.7 µg/l (mean ±SD);p<0.01), although there was a large overlap in the values. The 44 postmenopausal women also participated in a longitudinal clinical study, in which 20 received HRT and 24 received a placebo. Compared with the placebo group, those who received HRT had a significant (p<0.05) decrease in ICTP of about 12% at the end of 1 year of treatment, but again there was considerable overlap in the values. The menopause-and HRT-induced changes in ICTP were less than those seen in serum osteocalcin, serum total alkaline phosphatase, and fasting urinary excretion of hydroxyproline, calcium, pyridinoline and deoxypyridinoline. We conclude that the menopause increases and HRT decreases ICTP, although these changes are less pronounced than those seen in other biochemical markers of bone turnover.
Similar content being viewed by others
References
Delmas PD. Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. Am J Med 1991;91(Suppl 5B):59–63S.
Robey PG, Fisher LW, Young MF, Termine JD. The biochemistry of bone. In: Riggs BL, Melton LJ, editors. Osteoporosis: etiology, diagnosis and management. New York: Raven Press, 1988:95–109.
Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635–40.
Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 1993;8:127–32.
Riis BJ. Biochemical markers of bone turnover in diagnosis and assessment of therapy. Am J Med 1991;91(Suppl 5B):64–68S.
Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 1991;72:367–73.
Hassager C, Colwell A, Assiri AMA, Eastell R, Russell RGG, Christiansen C. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study. Clin Endocrinol 1992;37:45–50.
Hassager C, Fabbri-Mabelli G, Christiansen C. The effect of menopause and hormone replacement therapy on serum carboxy terminal propeptide of type I collagen. Osteoporosis Int 1993;3:50–2.
Marslew U, Overgaard K, Riis BJ, Christiansen C. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstet Gynecol 1992;79:202–10.
Johansen JS, Mølholm Hansen JE, Christiansen C. A radioimmunoassay for bone Gla-protein (BGP) in human plasma. Acta Endocrinol 1987;114:410–6.
The Committee of Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended methods for the determination of four enzymes in blood. Scand J Lab Clin Invest 1974;33:291–306.
Pødenphant J, Larsen N-E, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 1984;142:145–8.
Schlemmer A, Johansen JS, Pedersen SA, Jørgensen JOL, Hassager C, Christiansen C. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol 1991;35:471–6.
Pødenphant J, Engel U. Regional variation in histomorphometric bone dynamics from the skeleton of an osteoporotic woman. Calcif Tissue Int 1987;40:184–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hassager, C., Risteli, J., Risteli, L. et al. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen. Osteoporosis Int 4, 349–352 (1994). https://doi.org/10.1007/BF01622196
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01622196